Trial Outcomes & Findings for Impact of Cigarette and E-cigarette Flavors on Adult Smoking Behavior (NCT NCT04009850)

NCT ID: NCT04009850

Last Updated: 2024-03-08

Results Overview

Self-reported total number of cigarettes smoked per day (Timeline Follow Back)

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

3 participants

Primary outcome timeframe

Week 6

Results posted on

2024-03-08

Participant Flow

Participant milestones

Participant milestones
Measure
Menthol E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a menthol flavored e-cigarette Cigarette Brand Switching: Adult smokers will be switched from smoking menthol cigarettes to non-menthol cigarettes
Tobacco E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a tobacco flavored e-cigarette E-cigarette Flavor: Adult smokers will be provided with either menthol or tobacco flavored e-cigarettes in addition to the non-menthol cigarettes
Overall Study
STARTED
3
0
Overall Study
COMPLETED
3
0
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Impact of Cigarette and E-cigarette Flavors on Adult Smoking Behavior

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Menthol E-cigarette
n=3 Participants
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a menthol flavored e-cigarette Cigarette Brand Switching: Adult smokers will be switched from smoking menthol cigarettes to non-menthol cigarettes
Tobacco E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a tobacco flavored e-cigarette E-cigarette Flavor: Adult smokers will be provided with either menthol or tobacco flavored e-cigarettes in addition to the non-menthol cigarettes
Total
n=3 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
n=93 Participants
0 Participants
n=4 Participants
3 Participants
n=27 Participants
Age, Categorical
>=65 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Continuous
43.3 years
STANDARD_DEVIATION 13.6 • n=93 Participants
43.3 years
STANDARD_DEVIATION 13.6 • n=27 Participants
Sex: Female, Male
Female
1 Participants
n=93 Participants
1 Participants
n=27 Participants
Sex: Female, Male
Male
2 Participants
n=93 Participants
2 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants
n=93 Participants
3 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=93 Participants
1 Participants
n=27 Participants
Race (NIH/OMB)
White
2 Participants
n=93 Participants
2 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=27 Participants
Region of Enrollment
United States
3 participants
n=93 Participants
3 participants
n=27 Participants

PRIMARY outcome

Timeframe: Week 6

Population: No participants were enrolled in the tobacco e-cigarette condition.

Self-reported total number of cigarettes smoked per day (Timeline Follow Back)

Outcome measures

Outcome measures
Measure
Menthol E-cigarette
n=3 Participants
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a menthol flavored e-cigarette Cigarette Brand Switching: Adult smokers will be switched from smoking menthol cigarettes to non-menthol cigarettes
Tobacco E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a tobacco flavored e-cigarette E-cigarette Flavor: Adult smokers will be provided with either menthol or tobacco flavored e-cigarettes in addition to the non-menthol cigarettes
Total Number of Cigarettes Smoked
19 cigarettes per day
Standard Deviation 16

SECONDARY outcome

Timeframe: Week 6

Population: Analyses were not conducted for this outcome examining use by e-cigarette flavor condition because no participants were enrolled in the tobacco e-cigarette condition.

Self-reported e-cigarette use compared by e-cigarette flavor (Timeline Follow Back)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Week 6

Population: No participants were enrolled in the tobacco e-cigarette condition.

Self-reported subjective ratings of satisfaction with tobacco products (Modified Cigarette/E-cigarette Evaluation Questionnaire), rated 1-7 with higher scores indicating greater satisfaction

Outcome measures

Outcome measures
Measure
Menthol E-cigarette
n=3 Participants
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a menthol flavored e-cigarette Cigarette Brand Switching: Adult smokers will be switched from smoking menthol cigarettes to non-menthol cigarettes
Tobacco E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a tobacco flavored e-cigarette E-cigarette Flavor: Adult smokers will be provided with either menthol or tobacco flavored e-cigarettes in addition to the non-menthol cigarettes
Tobacco Product Satisfaction
1.7 units on a scale
Standard Deviation 1.6

SECONDARY outcome

Timeframe: Week 6

Population: No participants were enrolled in the tobacco e-cigarette condition.

Self-reported motivation to quit smoking cigarettes (Contemplation Ladder), rated 1-10, higher scores indicate greater motivation to quit

Outcome measures

Outcome measures
Measure
Menthol E-cigarette
n=3 Participants
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a menthol flavored e-cigarette Cigarette Brand Switching: Adult smokers will be switched from smoking menthol cigarettes to non-menthol cigarettes
Tobacco E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a tobacco flavored e-cigarette E-cigarette Flavor: Adult smokers will be provided with either menthol or tobacco flavored e-cigarettes in addition to the non-menthol cigarettes
Motivation to Quit Smoking
7.7 units on a scale
Standard Deviation 2.1

SECONDARY outcome

Timeframe: Week 6

Population: No participants were enrolled in the tobacco e-cigarette condition.

Self-reported nicotine dependence (NIH Promis Dependence Measure), rated 1-5, higher scores indicate greater dependence

Outcome measures

Outcome measures
Measure
Menthol E-cigarette
n=3 Participants
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a menthol flavored e-cigarette Cigarette Brand Switching: Adult smokers will be switched from smoking menthol cigarettes to non-menthol cigarettes
Tobacco E-cigarette
Adult smokers will be switched from using menthol cigarettes to non-menthol cigarettes and a tobacco flavored e-cigarette E-cigarette Flavor: Adult smokers will be provided with either menthol or tobacco flavored e-cigarettes in addition to the non-menthol cigarettes
Nicotine Dependence
3.8 score on a scale
Standard Deviation 1.1

Adverse Events

Menthol E-cigarette

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Tobacco E-cigarette

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Krysten Bold

Yale School of Medicine

Phone: 203-974-7603

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place